HomeUBX • NASDAQ
add
Unity Biotechnology Inc
Previous close
$1.49
Day range
$1.46 - $1.51
Year range
$1.46 - $3.82
Market cap
24.68M USD
Avg Volume
62.86K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 7.68M | 45.40% |
Net income | -4.34M | 69.38% |
Net profit margin | — | — |
Earnings per share | -0.28 | 72.00% |
EBITDA | -7.37M | 45.45% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 43.20M | -54.43% |
Total assets | 65.69M | -47.17% |
Total liabilities | 37.29M | -35.15% |
Total equity | 28.40M | — |
Shares outstanding | 15.74M | — |
Price to book | 0.83 | — |
Return on assets | -28.44% | — |
Return on capital | -33.11% | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -4.34M | 69.38% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Unity Biotechnology is a publicly traded American biotechnology company that develops drugs that target senescent cells. Wikipedia
Founded
2011
Headquarters
Website
Employees
19